Le Lézard
Classified in: Health, Science and technology
Subjects: NPT, CSR

Janssen and Leading Advocacy Organizations Introduce Cancer.com, a Customizable Online Destination for People Impacted by Cancer


HORSHAM, Pa., Dec. 13, 2017 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson are proud to announce the launch of Cancer.com, an online destination providing those impacted by cancer with useful information and tools at the right time. It features content tailored to each visitor by cancer type, topics of interest, and where they are in their care journey. Cancer.com also offers support tools to help visitors build skills to navigate life with cancer. It was created by Janssen Oncology in collaboration with leading patient advocacy organizations: the American Cancer Society, CancerCare, and Cancer Support Community.

"We understand that hearing the word 'cancer' is overwhelming, and the search that follows for relevant support can be daunting. This is what inspired Cancer.com," said Tom Cavanaugh, President, Janssen Biotech, Inc., Oncology. "As part of our enduring commitment to the cancer community and to working toward victories over cancer, we are excited to debut Cancer.com to educate and empower patients and their caregivers."

Customized Content

Cancer.com provides content tailored to when people are likely to need it most: at diagnosis, while making treatment decisions, during treatment, remission, and the potential of facing recurrence. Cancer types currently featured on Cancer.com include breast cancer, lung cancer, multiple myeloma, prostate cancer, and non-Hodgkin lymphoma. The site also provides a wide range of relevant insights across all tumor types.

Topic areas pinpoint what people impacted by cancer search for the most, including insurance and financial support, tips for effectively engaging with a healthcare team, and how to find local support ranging from clinical trial information to travel services.

Suite of Support Tools

Cancer.com offers unique resources, including My Care Activator, an exclusive digital health coaching tool developed by Johnson & Johnson behavior scientists that aims to pave a path toward better health outcomes. My Care Activator is customizable to visitors' specific needs and prioritizes behaviors that can be changed to help them build or strengthen important skills, such as coping with symptoms, working with a care team, asking for support, and getting appropriate exercise and better sleep.

Another tool, Advocacy Connector, identifies additional resources and support groups based on people's location, cancer type, and specific needs.

Designed for the Community, With Support from the Community

Janssen Oncology collaborated closely with three leading patient advocacy organizations ? the American Cancer Society, CancerCare, and Cancer Support Community ? each contributing to the deep content featured throughout Cancer.com. Cancer.com is also a gateway to other resources housed on these organizations' websites.

American Cancer Society: Chuck Westbrook, Senior Vice President, Cancer Control Programs and Services

"As a trusted resource for cancer information, the American Cancer Society is pleased to contribute its expertise and content to ensure people affected by cancer receive the most up-to-date information to make informed decisions about their health. The American Cancer Society is committed to attacking cancer from every angle. With the support of our partners, we can empower people with the information they need to navigate their cancer experience."

CancerCare: Patricia J. Goldsmith, Chief Executive Officer

"CancerCare has a broad and deep appreciation for how patients and families live with and beyond a cancer diagnosis. The customized and supportive approach of Cancer.com will assist many patients in understanding their diagnosis and their experiences throughout the continuum of care, as well as help them cope with the isolation and emotional challenges they will face."

Cancer Support Community: Hildy Dillon, MPH, Vice President, Education and Support Programs

"The Cancer Support Community has been documenting the cancer patient and caregiver experience for 35 years. Janssen approached us and our advocacy partners when Cancer.com was in the beginning stages of development. As a result, this new resource will include information and links to the services of each partner. We are proud to be part of Janssen's collaborative effort that brings so many benefits to the patient."

Visit Cancer.com today to learn more.

About the Janssen Pharmaceutical Companies

At the Janssen Pharmaceutical Companies of Johnson & Johnson, we are working to create a world without disease. Transforming lives by finding new and better ways to prevent, intercept, treat and cure disease inspires us. We bring together the best minds and pursue the most promising science. We are Janssen. We collaborate with the world for the health of everyone in it. Learn more at www.janssen.com. Follow us on Twitter at https://twitter.com/JanssenUS and https://twitter.com/JanssenGlobal.

About the American Cancer Society

The American Cancer Society is a global grassroots force of nearly 2 million volunteers dedicated to saving lives, celebrating lives, and leading the fight for a world without cancer. From breakthrough research, to free lodging near treatment, a 24/7/365 live helpline, free rides to treatment, and convening powerful activists to create awareness and impact, the Society is the only organization attacking cancer from every angle. For more information go to www.cancer.org.

About CancerCare

CancerCare is a leading national organization dedicated to providing free, professional support services including counseling, support groups, educational workshops, publications, and financial assistance to anyone affected by cancer. All CancerCare services are provided by oncology social workers and world-leading cancer experts.

About the Cancer Support Community

As the largest professionally led nonprofit network of cancer support worldwide, the Cancer Support Community (CSC), including its Gilda's Club affiliates, is dedicated to ensuring that all people impacted by cancer are empowered by knowledge, strengthened by action, and sustained by community. CSC achieves its mission through 3 areas: direct service delivery, research, and advocacy. The organization includes an international network of Affiliates that offer the highest quality social and emotional support for people impacted by cancer, as well as a community of support available online and over the phone. The Research and Training Institute conducts cutting-edge psychosocial, behavioral, and survivorship research. CSC furthers its focus on patient advocacy through its Cancer Policy Institute, informing public policy in Washington, DC, and across the nation.

SOURCE The Janssen Pharmaceutical Companies of Johnson & Johnson


These press releases may also interest you

at 22:33
The report titled "Identity Governance & Administration Market by Component (Services, Solution), Modules (Access Certification & Compliance Control, Access Management, Identity Lifecycle Management), Organization Size, Deployment, Vertical - Global...

at 22:03
The report titled "Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Global...

at 20:35
Bristow Group Inc. , the global leader in innovative and sustainable vertical flight solutions, today announced it will release its first quarter 2024 financial results and selected financial outlook for 2025 and 2026 after market close on Tuesday,...

at 20:25
AIDS Healthcare Foundation applauds the government of Colombia for issuing a compulsory license on HIV drug dolutegravir, which will allow the country to access affordable generic versions of the treatment as an alternative to the costly branded...

at 20:00
SUNRATE, an intelligent global payment and treasury management platform has been named one of the Top 100 Cross-Border Payment Companies for 2024 by FXC Intelligence, which recognises and celebrates the most important players in the cross-border...

at 19:35
Fobi AI Inc. (FOBI:TSXV) (FOBIF:OTCQB) (the "Company" or "Fobi"), an industry leader in harnessing AI and data intelligence to enable digital transformation, is pleased to announce that, further to its press release dated October 18, 2023, it has...



News published on and distributed by: